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a b s t r a c t
Introduction: Burn shock, a complex process, which develops following burn leads to severe
and unique derangement of cardiovascular function. Patients with preexisting comorbidities
such as cardiovascular diseases may be more susceptible. We therefore sought to examine
the impact of preexisting cardiovascular disease on burn outcomes.
Methods: A retrospective analysis of patients admitted to a regional burn center from 2002 to
2012. Independent variables analyzed included basic demographics, burn mechanism,
presence of inhalation injury, TBSA, pre-existing comorbidities, and length of ICU/hospital
stay. Bivariate analysis was performed and Poisson regression modeling was utilized to
estimate the incidence of being in the ICU and mortality.
Results: There were a total of 5332 adult patients admitted over the study period. 6% (n=428)
had a preexisting cardiovascular disease. Cardiovascular disease patients had a higher
mortality rate (16%) compared to those without cardiovascular disease (3%, p<0.001). The
adjusted Poisson regression model to estimate incidence risk of being in intensive care unit in
patients with cardiovascular disease was 33% higher compared to those without
cardiovascular disease (IRR=1.33, 95% CI=1.22–1.47). The risk for mortality is 42% higher
(IRR=1.42, 95% CI=1.10–1.84) for patients with pre-existing cardiovascular disease compared
to those without cardiovascular disease after controlling for other covariates.
Conclusion: Preexisting cardiovascular disease significantly increases the risk of intensive
care unit admission and mortality in burn patients. Given the increasing number of
Americans with cardiovascular diseases, there will likely be a greater number of individuals
at risk for worse outcomes following burn. This knowledge can help with burn
prognostication.
a r t i c l e i n f o
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Cardiovascular disease (CVDs) is the leading cause of death
and major cause of disability worldwide [1,2]. An estimated
17.5 million people died from CVDs in 2012, representing 31%
of all global deaths. Of these deaths, an estimated 7.4 million
were due to coronary heart disease and 6.7 million were due to
stroke. CVDs are a group of disorders of the heart and blood
vessels and include coronary heart disease with or without
heart failure, dysrhythmias, cardiomyopathy; cerebrovascular
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disease including aneurysmal diseases; peripheral arterial
disease; rheumatic heart disease– damage to the heart muscle
and heart valves; congenital heart disease– malformations of
heart structure existing at birth and deep vein thrombosis and
pulmonary embolism [3,4]. With the increase in longevity of
the US population, there is a concomitant rise in the number of
people with cardiovascular comorbidities that may also have
surgical needs.
The association between burn and cardiovascular dysfunc-
tion has long been established [5,6] with patients presenting
with “burn Shock”. This is a complex combination of
hypovolemic and cardiogenic shock with the later onset of a
septic component following burn. It leads to a profound,
persistent and unique derangement of cardiovascular func-
tion [7]. Derangements in cardiac function can last for two
years in pediatric patients with burns encompassing over
thirty percent of their total body surface area [8]. Factors that
influence outcomes following burn are well defined and they
include, percent total body surface area burn, presence of
inhalational injury, the extremes of age and burn wound
related sepsis. However, the effect of the resultant physiologic
changes on burn patients with pre-existing cardiovascular
diseases is as yet undefined.
There is anecdotal evidence to suggest that cardiovascular
comorbidities may adversely alter outcomes and indirect
evidence suggests that malperfusion contributes immensely
to increased mortality in patients with cardiac comorbidities
following traumatic injury but specific evidence in the burn
injured population is limited. In this study, we sought to
characterize the relationship between pre-existing cardiovas-
cular comorbidities and burn outcomes. We hypothesize that
patients with preexisting cardiovascular disease will have an
increased morbidity and mortality following burn.
2. Methods
This is a retrospective study of all burn patients admitted to the
North Carolina Jaycee Burn Center from 2002 to 2012. The
North Carolina Jaycee Burn Center at University of North
Carolina is an American Burn Association verified pediatric
and adult center. Established in 1981 and the center averages
more than 1200 acute admissions per year. The burn center is a
36-bed single unit facility.
The medical records of adult subjects (>18years) identified
by the UNC Burn database query were reviewed to verify
baseline demographic data, injury characteristics, and provide
detailed information on medical comorbidities and some
complications (i.e. cardiac). Injury characteristics of interest
included burn etiology, %TBSA burn, presence of inhalation
injury, and ventilation status on admission to the burn center.
Inhalation injury diagnosis was based on history, physical
examination, and/or bronchoscopic examination. Cardiac
complications include arrhythmias, myocardial infarction,
congestive heart failure, or cardiac arrest that occurred after
admission. Sepsis is recoded in the burn registry based on ICD-
9 codes. The cause of death for patients in the cohort is not
recorded in the burn registry.
To examine the effect of baseline medical comorbidities on
outcome, a Charlson Comorbidity Index (CCI) score was
calculated for each patient. The standardized Charlson Index
has been reported to accurately predict the probability of
mortality within 1year for a number of medical conditions
[9,10]. The score is the weighted sum of comorbid conditions.
There are 17 comorbid conditions included in the score and
each is assigned a weight from 1 to 6 points. The weighted sum
of all comorbid conditions is the patient’s Charlson score.
(Table 1) The CCI was also modified for this study to exclude
cardiovascular disease in order to elicit the independent effect
of cardiovascular disease on burn outcome. Pre-existing
comorbidities were identified utilizing the National Trauma
Data Bank (NTDB) from the American College of Surgeons
Committee on Trauma. It includes 27 different preinjury
comorbidities.
The primary outcomes of interest in this study were
mechanical ventilation and in-hospital mortality. Baseline
patient and injury characteristics were compared between
groups (CVD/no CVD) using Analysis of Variance for continu-
ous variables and chi-squared for discrete variables. We
employed both univariate and multivariate models to deter-
mine the relative influence of preexisting CVDs after control-
ling for covariates. To estimate the incidence rate ratios for
mechanical ventilation and mortality, we used a multivariate
Poisson regression model controlling for pertinent confound-
ers (age, TBSA, mechanism of injury, presence of inhalation
injury, comorbidities using CCI, and sepsis). Stata/MP (Version
12) (Stata Corp, College Station, TX) was used for all data
management and statistical analysis. The University of North
Carolina Institutional Review Board approved this study.
3. Results
A total of 5332 adult patients admitted during the study period
and included in our analysis. The median age was 41.8
(IQR=29.6–54.2) years with a male predominance at 3859 (72%).
Caucasians made up 2995 (56%) of the population. The most
common burn mechanism was flame (n=2936, 55%) followed
Table 1 – Charlson comorbidity index score system.
Comorbidity Score
Myocardial infarction 1
Congestive heart failure 1
Peripheral vascular disease 1
Cerebrovascular disease 1
Dementia 1
Chronic pulmonary disease 1
Rheumatologic disease 1
Peptic ulcer disease 1
Mild liver disease 1
Diabetes without chronic complications 1
Diabetes with chronic complications 2
Hemiplegia or paraplegia 2
Renal disease 2
Any malignancy, including leukemia and lymphoma 2
Moderate or severe liver disease 3
AIDS/HIV 6
Metastatic solid tumor 6
Maximum comorbidity score 33
by scald injury (n=2006, 38%). The overall median %TBSA for
this population was 5 (IQR=2–11) %. (Table 2) The mean
hospital, ICU length of stay, and days of mechanical ventilation
was 15.027.3days, 17.435.8days, and 26.138.4days re-
spectively. Burn patients with at least one comorbidity
represented 55% of the population (n=2915). A total of 428
(8%) patients had pre-existing cardiovascular disease prior to
burn. For this subset of patients, cardiovascular diseases
present were coronary artery disease (n=272, 63%), cardiac
arrhythmias (n=145, 33%), myocardial infarction (n=121, 28%),
congestive heart failure (n=127, 30%), stroke (n=83, 19%),
peripheral vascular disease (n=63, 15%), and heart valve
abnormality (n=70, 16%). In the entire cohort, known risk
factors for cardiovascular disease included concurrent smok-
ers (n=1382, 26%), hypertension (n=1037, 19%), diabetes
(n=603, 11%), and obesity (n=139, 3%). A total of 181 (3%)
patients experienced in-hopsital cardiac complications.
3.1. Cardiovascular disease
A bivariate analysis was performed to compare patients with
preexisting cardiovascular disease (PCVD) and without pre-
existing cardiovascular disease (NCVD). The median age for
PCVD vs NCVD was 63.4 (IQR=54.5–73.5)years and 40.0
(IQR=28.7–51.7)years, respectively (p<0.001). (Table 3) There
was a no significant difference between the two groups based
on %TBSA, race or gender. PCVD patients had a higher
modified CCI score (1.651.61) compared to NCVD patients
(0.350.92, p<0.001). For risk factors, preexisting cardiovas-
cular disease patients have significantly higher rates of
smoking (33% vs 25%, p<0.001), hypertension (53% vs. 17%,
p<0.001), diabetes (42% vs 9%, p<0.001), and obesity (7% vs 2%,
p<0.001) compared to NCVD patients. Approximately, 15% (vs.
2%) patients with PVD had cardiac complications and 9% (vs.
3%) developed sepsis (p<0.001). Inhalation injury was higher
in PCVD patients compared to NCVD patients (14% vs. 9%,
p<0.001). The crude mortality rate was higher for patients with
PCVD (15% vs. 4%, p<0.001). Patients with PCVD had statisti-
cally significant increase in hospital-LOS (25.036.9days vs.
14.126.1 days, p<0.001), ICU-LOS stay (13.632.1days vs. 5.9
22.4 days, p<0.001), and ventilator days (8.8days vs. 3.8days,
p<0.001) compared to NCVD patients.
A multivariate Poisson regression model was utilized to
determine the incidence risk of intensive care unit admission
and burn mortality in the PCVD vs. CVD subgroups after
adjusting for significant covariates. Patients with PCVD were in
the intensive care unit 30% more (IRR=1.30 (NCVD reference
group), 95% CI=1.19–1.43). (Table 4) The cumulative risk for
patients with preexisting cardiovascular disease for ICU
admission was higher than NRD patients over the first 100days
of hospital stay. (Fig. 1) The unadjusted incidence of
mortality for patients with PCVD is 3.41 times that of NCVD
patients (IRR=3.41 (NCVD reference group), 95% CI=2.63–
4.42). However, the risk ratio for mortality is 46% higher
(IRR=1.46 (NCVD reference group), 95% confidence interval:
1.13–1.90) after adjustment of patient demographics, injury
characteristics, and in-hospital complications (Table 5,
Fig. 2). When patients are group based on presence of
cardiovascular disease, patients with preexisting cardiovas-
cular disease were at higher cumulative risk of mortality
than non-cardiovascular disease patients over the length of
hospitalization (Fig. 2).
4. Discussion
In this study, we have shown that burn patient with
preexisting cardiovascular comorbidities have an increased
intensive care unit admission and significantly higher risk of
mortality compared to burn patients without pre-existing
cardiovascular diseases.
Studies in the general trauma population reveal similar
findings to ours. Ferraris et al. studied the relationship
between preexisting cardiac disease and mortality in
5971 trauma patients over a 5-year period. The study revealed
that the most significant cardiovascular risk of trauma death
were preinjury use of Coumadin, a surrogate for dysrhythmias
or deep vein thrombosis/pulmonary embolism (OR=2.309),
Table 2 – Patient characteristics.
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and congestive heart failure (OR=2.060). The mortality rate
was highest in patients with a combination of these cardio-
vascular factors, especially if the patient was on Coumadin
prior to admission [11]. In a study examining burn outcomes
associated with comorbidities over a shorter time period,
Akhtar et al. also found that cardiac disease had the highest
mortality rate (10.5%) compared to other chronic diseases but a
similar length of hospital stay (5weeks) [12].
The only prior study that specifically examined mortality
following burn in patients with and without prior CVD
reviewed 2477 consecutive burn admissions and observed
the incidence of cardiac complications in patients with burns.
Forty-six percent of patients with CVD prior to burn experi-
enced at least one cardiac event during the hospitalization.
Cardiac complications include arrhythmias, hypotension,
congestive heart failure, myocardial infarction, and cardiac
arrest. For patients with history valvular disease, the average
burn size (%TBSA) ranged from 16 to 29% that had cardiac
dysfunction. The mean %TBSA for those who suffered a
myocardial infarction was 30.3%. The mortality rate for those
patients with cardiac history was 30%. In comparison to
patients without a cardiac history, the in-hospital mortality
rate following myocardial infarction was 3.5–4 times higher for
those with a cardiac history [13].
Table 3 – Bivariate analysis of burn patients (with and without preexisting cardiovascular disease).
Cardiovascular disease (n=428) No cardiovascular disease (n=4903) p-Value
Age 63.4 (IQR=54.5–73.5) 40.0 (IQR=28.7–51.7) <0.001
TBSA 10.2 (IQR=2–13) 9.3 (IQR=2–10) 0.115
mCCI 1.65 (1.61) 0.35 (0.92) <0.001
Race 0.060
White 259 (61%) 2735 (56%)
Other 169 (39%) 2165 (44%)
Gender 0.418
Male 317 (74%) 3542 (72%)
Female 111 (26%) 1361 (28%)
Mechanism 0.014
Flame 264 (62%) 2671 (55%)
Scald 136 (32%) 1870 (38%)
Other 24 (6%) 325 (7%)
Smoker 142 (33%) 1240 (25%) <0.001
HTN 228 (53%) 810 (17%) <0.001
Obesity 31 (7%) 118 (2%) <0.001
Diabetes 180 (42%) 422 (9%) <0.001
Cardiac complications 64 (15%) 117 (2%) <0.001
Sepsis 37 (9%) 128 (3%) <0.001
Inhalation injury 62 (14%) 461 (9%) 0.001
Crude mortality rate 65 (15%) 216 (4%) <0.001
ICU LOS 13.6 (32.1) 5.9 (22.4) <0.001
Length of hospital stay 25.0 (36.9) 14.1 (26.1) <0.001
Mechanical ventilation 8.8 (29.1) 3.8 (16.9) <0.001
TBSA=total body surface area.
mCCI=Charlson comorbidity index excluding preexisting cardiovascular diseases.
HTN=Hypertension.
ICU LOS=intensive care unit length of stay.
Table 4 – Multivariate Poisson regression for being in ICU admission in burn cohort.
Variable Adjusted incidence rate ratio, 95% confidence interval (CI) p-Value
Age 1.01 (1.00–1.01) <0.001
TBSA 1.01 (1.01–1.02) <0.001
Mechanism
Flame (reference group)
Scald 0.61 (0.55–0.67) <0.001
Other 1.54 (1.39–1.71) <0.001
mCCI 1.05 (1.02–1.08) <0.001
Inhalation injury 1.91 (1.80–2.03) <0.001
Sepsis 1.17 (1.08–1.28) <0.001
Cardiac Complications 1.29 (1.17–1.42) <0.001
Cardiovascular Disease 1.30 (1.18–1.43) <0.001
TBSA=total body surface area.
mCCI=Charlson comorbidity index excluding cardiovascular diseases.
The specific drivers and pathophysiologic mechanisms
that predispose burn patients with PCVD to increased
mortality are not well delineated as we cannot directly
attribute the cause of death to cardiovascular disease without
an autopsy. However, it is clearly established that severe burn
is complicated by a surge of plasma catecholamines that
mediate the profound hypermetabolic response. The elevated
levels of plasma catecholamines instigate cardiac stress after
Fig. 1 – Cumulative risk for intensive care unit admission in patients with and without pre-existing cardiovascular disease.
Table 5 – Multivariate Poisson regression for in-hospital mortality in burn cohort.
Variable Adjusted incidence rate ratio, 95% confidence interval (CI) p-Value
Age 1.04 (1.03–1.05) <0.001
TBSA 1.04 (1.04–1.05) <0.001
Mechanism
Flame (reference group)
Scald 0.61 (0.43–0.86) 0.005
Other 1.44 (0.79–2.60) 0.230
LOS 0.98 (0.97–0.99) 0.011
Mechanical ventilation 1.02 (1.00–1.04) 0.013
mCCI 1.11 (1.03–1.20) 0.008
Inhalation injury 1.81 (1.46–2.24) <0.001
Sepsis 3.06 (2.18–4.29) <0.001
Cardiac complications 1.60 (1.16–2.22) 0.004
Cardiovascular disease 1.46 (1.13–1.90) 0.004
TBSA=total body surface area.
LOS=length of hospital stay.
mCCI=Charlson comorbidity index excluding cardiovascular diseases.
Fig. 2 – Cumulative risk for mortality in patients with and without pre-existing cardiovascular disease.
burn. [14] The effects of a sustained release of large amounts of
circulating catecholamines are detrimental to the myocardi-
um. The resultant increased sympathetic drive results in
anticipated increased myocardial oxygen delivery and myo-
cardial oxygen consumption. In the presence of preexisting
cardiovascular disease, such as coronary arterial disease or
cardiac arrhythmias, the resultant cardiac response may be
inadequate to meet needs leading to local myocardial hypoxia,
focal degeneration of the myocardium, cardiac instability and
cardiac death, and physiologic exhaustion [15–17].
In this study, we controlled for inhalation injury, we
recognize that the presence of identifiable (carbon monoxide)
and other non-identifiable toxins creates a hypoxic intracel-
lular environment that results in myocardial damage, which
can lead to dysrhythmias, new onset or worsening congestive
heart failure, hypotension, or acute myocardial infarction [18].
In addition, the massive fluid shifts associated with burn
resuscitations may result in additional life-threatening com-
plications as pulmonary edema and abdominal compartment
syndrome that may predispose burn patients with cardiovas-
cular disease to increased risk of death [19–21].
The pathophysiology of cardiac dysfunction in burns is
increasingly recognized, however, evidence guiding the
treatment remains elusive. Strategies to mitigate the poor
outcomes in the subset of burn patients with preexisting
cardiovascular disease should include early recognition of the
type of preexisting CVD and the institution of critical care. The
prevention of burn shock should be an early goal. Balanced
fluid resuscitation with hemodynamic end points to avoid
over-resuscitation and perhaps the use of goal directed
resuscitation using invasive or non-invasive adjuncts such
as the pulmonary artery or other thermodilution cardiac
monitor catheters or cardiac ultrasound, respectively.
Following the resuscitation period, the attenuation of the
catecholamine response should be attempted. During this
phase, complications such as cardiac arrhythmias, myocardial
infarctions, and cardiac instability may manifest and the use
of B-blockers may be considered. Previous studies in burn
patients have shown significant promise with the use of B-
Blockers to attenuate the hypermetabolic response and
reverse muscle protein catabolism [22]. The use of propranolol
also improved cardiac function and lowered the heart rate
while maintaining adequate cardiac output [23]. Studies on
use of B-blockers in adults have shown improved burn
outcomes such as decreased mortality rate and improved
wound healing [24]. In terms of burn mortality, patients who
were able to achieve greater cardiac output and oxygen
delivery had better survival outcomes [25].
The limitations of this study are those inherent to any
retrospective study. As a large burn center, presentation bias
may have affected our patient mix as more complicated burn
were sent to our center. Though this is a single center study, our
sample size was robust enough not to affect the generalizability
of our findings. The pre-existing comorbidities were abstracted
from documented diagnosed based on ICD-9 codes and hence
subject to interpretation. All cardiovascular diseases were
groups were categorized as one entity and the individual
contribution of each individual cardiovascular disease and its
weight on burn mortality was not analyzed. The contribution of
frailty and its effect on to outcome was not evaluated. An
alternative would be the use of the APACHE score on admission
which gives a better indication of health status on admission
but the APACHE score has not been validated in a large cohort
of burn patients. Furthermore, the Charlson comorbidity
index was originally based on the predictive power to estimate
mortality in medicine patients and was never intended to
generalizations to surgical or burn cohort.
5. Conclusion
Preexisting cardiovascular disease significantly increases the
risk of intensive care unit admission and burn mortality. Our
findings re-emphasizes the need for the inclusion of comor-
bidities in any burn mortality prediction models so as to better
inform burn mortality prognostication. Understanding of the
pathophysiology of cardiovascular dysfunction and how the
additional stress of burn can affect the underlying cardiovas-
cular disease process is critical to the successful patient
management in this burn population to reduce mortality.
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